<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01074723</url>
  </required_header>
  <id_info>
    <org_study_id>AGL-2008-02591-C02-02</org_study_id>
    <nct_id>NCT01074723</nct_id>
  </id_info>
  <brief_title>B-cryptoxanthin and Phytosterols on Bone Remodeling and Cardiovascular Risk Factors</brief_title>
  <official_title>Bioavailability of Added B-cryptoxanthin and Phytosterols; In Vitro and in Vivo Interactions and Effect on Bone Remodelling and Cardiovascular Risk Markers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Puerta de Hierro University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Puerta de Hierro University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We, the investigators, aim to study, in vitro and in vivo, the bioavailability of added
      b-cryptoxanthin and phytosterols and evaluate in vivo its effect on biochemical markers of
      bone remodelling and cardiovascular risk. Specifically, we will 1) assess the stability in
      the food and the bioavailability of b-cryptoxanthin in the presence of phytosterols
      (absorption modifiers) by using a complementary approach; in vitro and in vivo studies; and
      2) we will study in post-menopausal women (target group) the biological effect (bioefficacy)
      associated with the regular consumption of modified milk-based fruit beverages (containing
      b-cryptoxanthin and phytosterols) by assessing changes in biochemical markers of bone
      turnover and cardiovascular risk.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum b-cryptoxanthin</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum Cardiovascular risk markers</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum bone markers</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genetic variability (polymorphisms)and DNA oxidative damage</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Postmenopausal Disorder</condition>
  <arm_group>
    <arm_group_label>b-cryptoxanthin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>phytosterols</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>b-cryptoxanthin plus phytosterols</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>b-cryptoxanthin and phytosterols</intervention_name>
    <description>Fruit juices containing b-cryptoxanthin (ca. 1 mg), phytosterols (ca 1.7g) or both will be consumed for 4 weeks with a 4-week washout in between.</description>
    <arm_group_label>b-cryptoxanthin</arm_group_label>
    <arm_group_label>phytosterols</arm_group_label>
    <arm_group_label>b-cryptoxanthin plus phytosterols</arm_group_label>
    <other_name>carotenoids, plant sterols</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Post-menopausal women, 45-60 years old

        Exclusion Criteria:

          -  Dieting

          -  Food allergy (to any components provided)

          -  Hormone replacement therapy

          -  Cholesterol lowering drugs, antiresorptive or anabolic bone drugs

          -  Calcium and vitamin D supplements

          -  Soybean products

          -  Vitamin-mineral supplements

          -  Fibre supplements

          -  Commercially available enriched foods (i.e. w-3, phytosterols,carotenoids,...)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Puerta de Hierro University Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2010</study_first_submitted>
  <study_first_submitted_qc>February 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2010</study_first_posted>
  <last_update_submitted>February 7, 2014</last_update_submitted>
  <last_update_submitted_qc>February 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Puerta de Hierro University Hospital</investigator_affiliation>
    <investigator_full_name>Fernando Granado Lorencio</investigator_full_name>
    <investigator_title>Dr. Fernando Granado lorencio</investigator_title>
  </responsible_party>
  <keyword>b-cryptoxanthin</keyword>
  <keyword>cholesterol</keyword>
  <keyword>bone markers</keyword>
  <keyword>Osteoporosis</keyword>
  <keyword>cardiovascular risk</keyword>
  <keyword>post-menopausal women</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

